WEAVER CONSULTING GROUP – Edwards Lifesciences Corporation Transaction History
WEAVER CONSULTING GROUP portfolio value:
$3.26M
portfolio value
WEAVER CONSULTING GROUP quarter portfolio value change:
-13.10%
quarter
Edwards Lifesciences Corporation 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.19% | 76 shares | -486K | $82.63 | 39.55K |
| Q2 2022 | share | Increase | +1.41% | 549 shares | -828K | $95.09 | 39.47K |
| Q1 2022 | share | Increase | +0.52% | 200 shares | -435K | $117.72 | 38.92K |
| Q4 2021 | share | Increase | +0.01% | 3 shares | 633K | $130.68 | 38.72K |
| Q3 2021 | share | Increase | +0.31% | 118 shares | 386K | $113.21 | 38.72K |
| Q2 2021 | share | Increase | +2.06% | 780 shares | 834K | $103.57 | 38.60K |
| Q1 2021 | share | Increase | +4.11% | 1.49K shares | -150K | $83.64 | 37.82K |
| Q4 2020 | share | Increase | +1.89% | 675 shares | 468K | $91.23 | 36.33K |
| Q3 2020 | share | Increase | +4.62% | 1.57K shares | 491K | $79.82 | 35.65K |
| Q2 2020 | share | Decrease | -1.91% | -663 shares | 171K | $69.11 | 34.08K |
| Q1 2020 | share | Increase | +1.87% | 639 shares | -316K | $62.87 | 34.74K |
| Q4 2019 | share | Increase | +4.17% | 1.36K shares | 133K | $77.76 | 34.10K |
| Q3 2019 | share | 0.00% | 0 shares | 351K | $73.3 | 32.73K | |
| Q2 2019 | share | Decrease | -1.18% | -390 shares | -29K | $61.58 | 32.73K |
| Q1 2019 | share | Increase | 0.00% | 33.12K shares | 2.04M | $63.78 | 33.12K |